Long COVID with fatigue for nearly three years, somewhat better on low-dose naltrexone
- Condition
- Long COVID
- At worst
- Not stated
- Ill before improving or writing
- 3 years
- Last post
- Feb 2026
In their words
- Condition: Long COVID
I’ve had long covid going on 3 years this April
In context ↗ - Now: Somewhat better
the LDN has definitely helped with my fatigue. I’ve had long covid going on 3 years this April, and been on LDN for 5 months - noticeably difference.
In context ↗ - Began after: COVID
I’ve had long covid going on 3 years this April
In context ↗
Summary
Valley 53942 has had long COVID for nearly three years and still has a heart rate issue during exercise. Low-dose naltrexone, taken for five months, noticeably reduced fatigue; they also saw improvements in daily activities and heart rate, though the heart rate during exercise stayed unsolved. Indica edibles of 2.5-5 mg at night helped them get to sleep and relax; early on they magnified some neurological symptoms, which later stopped.
Ask Miruvor AI
What they tried
What they credit
Also tried
Their words about each treatment
- LDN · Helped
I’ve had long covid going on 3 years this April, and been on LDN for 5 months - noticeably difference. ... the LDN has definitely helped with my fatigue
In context ↗ - indica Edibles · Helped
2.5-5mg indica Edibles at night definitely help me get to sleep and relax. Early on, it would magnify certain neurological symptoms, but that improved over time
In context ↗
Their path
They say too little about how ill they were at each step to draw it on the severity scale, so the steps are listed as they describe them. Dates are when they posted.
| When | What happened | After |
|---|---|---|
| April 2023 | long COVID beganI’ve had long covid going on 3 years this AprilIn context ↗ | |
| 2026-01-24 | fatigue and daily activities improved on LDNthe LDN has definitely helped with my fatigue ... noticeably differenceIn context ↗ | Low-dose naltrexone |
| 2026-02-08 | sleeping and relaxing better with edibles2.5-5mg indica Edibles at night definitely help me get to sleep and relaxIn context ↗ |
Adverse events
- Cannabis (THC, marijuana)“Early on, it would magnify certain neurological symptoms, but that improved over time, don’t have any unwanted sensations or symptoms now.” In context ↗ Made symptoms worse
Symptoms mentioned
Their words about their symptoms
- POTS & dysautonomia
the dysautonomia or the higher than normal heart rate (which I still haven’t solved while working out, but I’ve seen improvements in daily activities and my heart rate)
In context ↗ - Sleep problems
2.5-5mg indica Edibles at night definitely help me get to sleep and relax
In context ↗
Ask Miruvor AI
Similar stories
-
Mostly housebound with ME/CFS, now a little better on Klonopin and low-dose naltrexone
Joseph, 47, in Los Angeles, developed ME/CFS in January 2024, about 18 days after a second COVID infection. He declined from mild to the bad end of moderate over six months, becoming mostly housebound. Klonopin, low-dose naltrexone, midodrine and propranolol…
-
Long COVID brain fog, somewhat better with nicotine patch and naltrexone
Pebble 25278 developed long COVID with brain fog, distorted smell, headaches, nerve pain and trouble sleeping. A quarter of a 10 mg nicotine patch restored much of their speech and thinking, and low-dose naltrexone further raised their cognitive and physical…
-
Almost bedridden with ME/CFS, now much better after a specialist regimen and pacing
A California woman infected with COVID in March 2020 was sick six months, partly recovered, then relapsed and was almost bedridden by early 2023, unable to drive and sensitive to light and noise. An out-of-pocket ME/CFS specialist regimen of LDN, Abilify,…
-
Bedbound with ME/CFS, now housebound and somewhat better with rest and low-dose naltrexone
After about 1.5 years of ME/CFS with push–crash cycles, they became bedbound for two months in mid-2026, getting up only for the bathroom. They improved slowly with four months of rest, low-dose naltrexone, a beta-blocker, compression and salt/fluids. By…